BVA-100
Device
Daxor Corporation
Total Payments
$707,746
Transactions
975
Doctors
580
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $270,555 | 401 | 279 |
| 2023 | $311,823 | 403 | 280 |
| 2022 | $125,368 | 171 | 90 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $369,628 | 124 | 52.2% |
| Unspecified | $235,757 | 31 | 33.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,208 | 27 | 5.0% |
| Food and Beverage | $30,052 | 746 | 4.2% |
| Honoraria | $21,728 | 14 | 3.1% |
| Travel and Lodging | $15,094 | 26 | 2.1% |
| Education | $280.00 | 7 | 0.0% |
Payments by Type
General
$471,989
944 transactions
Research
$235,757
31 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Evaluation of Blood Volume Analysis-Guided Management of Decompensated Heart Failure | Daxor Corporation | $146,083 | 0 |
| Monitoring Outpatient Blood VolumE in Heart Failure (MOVE-HF) | Daxor Corporation | $75,816 | 0 |
| Validation Study for Next Generation BVA | Daxor Corporation | $10,650 | 0 |
| Monitoring Outpatient Blood VolumE in Heart Failure ( MOVE-HF ) | Daxor Corporation | $3,208 | 0 |
Top Doctors Receiving Payments for BVA-100 — Page 24
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Manjot Mashiana | Family Medicine | Tupelo, MS | $3.63 | 1 |
| , D.O | Family Medicine | Tupelo, MS | $3.63 | 1 |
| , MD | Family Medicine | Tulsa, OK | $2.47 | 1 |
| , MD | Family Medicine | Jackson, TN | $2.47 | 1 |
| , M.D | Gastroenterology | Oklahoma City, OK | $2.47 | 1 |
| , MD | Internal Medicine | Chicago, IL | $2.47 | 1 |
Ad
Manufacturing Companies
- Daxor Corporation $707,746
Product Information
- Type Device
- Total Payments $707,746
- Total Doctors 580
- Transactions 975
About BVA-100
BVA-100 is a device associated with $707,746 in payments to 580 healthcare providers, recorded across 975 transactions in the CMS Open Payments database. The primary manufacturer is Daxor Corporation.
Payment data is available from 2022 to 2024. In 2024, $270,555 was paid across 401 transactions to 279 doctors.
The most common payment nature for BVA-100 is "Consulting Fee" ($369,628, 52.2% of total).
BVA-100 is associated with 4 research studies, including "Evaluation of Blood Volume Analysis-Guided Management of Decompensated Heart Failure" ($146,083).